Letter: rationalising aminosalicylates in inflammatory bowel disease
- 21 October 2020
- journal article
- letter
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 52 (10) , 1619-1620
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Review article: withdrawal of 5‐aminosalicylates in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2020
- Aminosalicylate withdrawal following escalation to immunomodulators or biologics in ulcerative colitis: cost saving, convenient and does not compromise efficacyGastroHep, 2020
- Systematic review: molecular chemoprevention of colorectal malignancy by mesalazineAlimentary Pharmacology & Therapeutics, 2009
- Studies of compliance with delayed‐release mesalazine therapy in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2003